Table 4.
Variable | 1. Multivariate hazard ratio (CI) |
2. Multivariate hazard ratio (CI) |
3. Multivariate hazard ratio (CI) |
4. multivariate hazard ratio (CI) |
---|---|---|---|---|
Cardiovascular/clinical risk factors | ||||
Age | ||||
Smoking | ||||
Hypertension | ||||
Diabetes | ||||
Killip class | ||||
Atrial fibrillation | ||||
Angiography | ||||
Diseased vessels | ||||
Culprit lesion | ||||
CMR-derived morphology | ||||
IS | ||||
MVO | ||||
MSI | ||||
LAVI | ||||
CMR-derived function a | ||||
LVEF | ||||
LV GLS | 1.11 (1.02–1.20) P = 0.013 |
1.11 (1.02–1.20) P = 0.011 |
1.10 (1.02–1.20) P = 0.015 |
1.11 (1.03–1.20) P = 0.010 |
1 LA Es | ||||
2 LAEF | 0.96 (0.92–0.99) P = 0.017 |
|||
3 LA LAS | 0.90 (0.82–0.99) P = 0.036 |
|||
4 LA LAS90 | 0.92 (0.84–1.00) P = 0.050 |
The table reports multivariable Cox regression models (based on the enter method) to predict a major adverse clinical event during the 12 months follow-up period following acute myocardial infarction. Data are presented as hazard ratios with associated 95% confidence intervals in parentheses. Variables with univariate significance (P < 0.05) were included in multivariable Cox regression models and are presented if they emerged as statistically significant (P < 0.05).
CI, confidence interval; HLP, hyperlipoproteinaemia; BMI, body mass index; IS, infarct size; MVO, microvascular obstruction; MSI, myocardial salvage index; LVEF, left-ventricular ejection fraction; LAVI, left-atrial volume index; GLS, global longitudinal strain; Es, reservoir function; LAS, long-axis strain.
LA Es, LAEF, and LAS/LAS90 were considered in separate multivariate models due to their high correlation (Models 1–4).